Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy ESGCT.

Keywords: Biological Therapy; Biomedical Engineering; Biomedicine; Biopharmaceutical Companies; Biotechnology; Business; Cell Therapy; Drugs and Therapies; Genetics; Health and Medicine; Healthcare Biotechnology Companies; Inflammation; Neurology; Protein Expression; Proteomics; Sangamo Therapeutics Inc.; Therapy EN Biological Therapy Biomedical Engineering Biomedicine Biopharmaceutical Companies Biotechnology Business Cell Therapy Drugs and Therapies Genetics Health and Medicine Healthcare Biotechnology Companies Inflammation Neurology Protein Expression Proteomics Sangamo Therapeutics Inc. Therapy 1409 1409 1 11/06/23 20231106 NES 231106 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced that the European Society of Gene & Cell Therapy (ESGCT) has accepted six Sangamo abstracts for presentation at the 30th Annual Congress being held October 24-27, 2023, in-person in Brussels, Belgium. Biological Therapy, Biomedical Engineering, Biomedicine, Biopharmaceutical Companies, Biotechnology, Business, Cell Therapy, Drugs and Therapies, Genetics, Health and Medicine, Healthcare Biotechnology Companies, Inflammation, Neurology, Protein Expression, Proteomics, Therapy, Sangamo Therapeutics Inc. [Extracted from the article]

Copyright of Pharma Business Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)